POLISCOPE
Back to bills
Part ofHealth →

The civic record

Read. Follow. Verify.

New Jersey creates Overdose Fatality and Near Fatality Review Board to investigate substance-related deaths

Original title: Establishes Overdose Fatality and Near Fatality Review Board.

Last action · January 13, 2026: Introduced, Referred to Assembly Health CommitteeSponsors: Clifton, Robert D. and 1 other

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

The New Jersey Legislature established the 13-member Overdose Fatality and Review Board within the Department of Human Services to examine overdose deaths and severe incidents, identify systemic causes, and recommend prevention strategies. The board is authorized to establish local review teams, subpoena relevant records, maintain confidential case files, and report annually to the Governor and Legislature.

Why it matters

Establishes a centralized state entity with subpoena powers over medical, school, and treatment records to investigate overdose cases and coordinate agency responses, while shielding board members from civil liability for good-faith reporting.

Background
  • Assemblyman Robert D. Clifton represents New Jersey's 12th Legislative District. context
  • State overdose fatality review teams are utilized across various jurisdictions to analyze systemic gaps in addiction treatment and emergency response. context

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Substance use disorder treatment providers

Providers may have patient treatment records subpoenaed and reviewed by the board and are represented on review teams.

Directly affected

State and local law enforcement agencies

Law enforcement personnel participate in local review teams, and the board must notify county prosecutors if a case involves another person's criminal actions.

Directly affected

New Jersey residents

Residents are impacted by state policy recommendations and prevention initiatives developed from the board's reviews.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What is the main purpose of the Overdose Fatality and Near Fatality Review Board?
The board's purpose is to review overdose deaths and near fatalities in New Jersey, identify their causes and relationship to governmental support systems, evaluate government responses, and recommend prevention methods and policy improvements.
Will personal identifying information from the review files be made public?
No. The board must record identifying information in a confidential master file that is not subject to discovery, and all summary records prepared by the board and its teams must be free of identifying information.
Who serves on the review board?
The board consists of 13 members, including state officials like the Commissioners of Health and Human Services, Attorney General, Superintendent of State Police, State Medical Examiner, and Executive Director of the Governor’s Council on Alcoholism and Drug Abuse, plus seven public members appointed by the Governor representing prosecution, addiction prevention, and treatment fields.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

1 action
  1. Jan 13, 2026HouseIntroduced
    Introduced, Referred to Assembly Health Committee

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Clifton, Robert D.Primary sponsorNo profile match
DePhillips, Christopher P.Primary sponsorNo profile match

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift95% confidence

Centralized State Oversight for Overdose Reviews

The legislation shifts from isolated agency reviews to a coordinated, multidisciplinary state board with specialized subpoena powers across medical, school, and treatment records.

Sources

Open source document

njleg.state.nj.us

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record